Tag: entrepreneurs
-

Cardiac Tech Start-Up Partners with Mayo Clinic
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks.
-

Small Biz Award Funds Wearable Drug Delivery Patch
A developer of medical devices designed as skin patches received a contract to develop a device to deliver any drug approved by FDA for delivery through the skin.
-

FDA Clears Biotech Seasonal Flu Treatment Trial
A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains.
-

Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-

Genomics Company, Amazon Partner on Generative A.I.
A genomics company is providing precision medicine analytics from its databases with generative A.I. based on large language models from Amazon Web Services.
-

Biosensor Developed to Detect Explosives, Land Mines
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances.
-

University Start-Up Developing Inhaled Gene Therapies
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
-

Small Biz Grant Supports Regenerative Alzheimer’s Treatment
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease.
-

Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-

Venture Firm, Cancer Center Start Antibody Biotech Company
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets.